Oxford Asset Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Oxford Asset Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,051	Closed	-$557K	–	1451
2019 Q4	$557K	Buy	4,051 +505	+14%	+$61.4K	0.02%	1188
2019 Q3	$421K	Buy	3,546 +1,579	+80%	+$220K	0.01%	1330
2019 Q2	$275K	Sell	1,967 -3,949	-67%	-$693K	0.01%	1470
2019 Q1	$1.06M	Sell	5,916 -3,541	-37%	-$532K	0.02%	901
2018 Q4	$1.49M	Buy	+9,457	New	+$1.41M	0.04%	645

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Oxford Asset Management's ORTX Position: Q1 2020 in Review

Oxford Asset Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2020, closing a stake of 4,051 shares — an estimated $557K sold.

Oxford Asset Management first reported a position in ORTX in Q4 2018 and held it in 5 quarters. The position peaked at $1.49M in Q4 2018. 74 funds tracked by Wall St. Rank hold ORTX as of Q1 2020.

Oxford Asset Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 4,051 Orchard Therapeutics plc American Depositary Shares shares in Q1 2020, an estimated $557K.
Oxford Asset Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 5 quarters.
Oxford Asset Management's Orchard Therapeutics plc American Depositary Shares position peaked at $1.49M in Q4 2018.
74 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.